BARD1 Life Sciences Limited Dividend 2022

BARD1 Life Sciences Ltd (BD1) is an Australian life sciences company focused on developing and commercializing non-invasive diagnostic tests for early detection of cancer. BARD1’s proprietary technology platform is based on novel tumour markers with potential diagnostic and therapeutic applications across multiple cancers. The pipeline includes two development-stage BARD1 autoantibody tests for early detection of lung and ovarian cancers, and a research-stage cancer vaccine under evaluation for treatment of cancer.

BARD1 Life Sciences Limited operators in Health Care sector and under industry of Health Care Services. The company website is:

You can also check out dividend history for similar stocks in the same sector as follows:

BD1 Dividend Dates

Please click the table header to sort the data.

No Dividend Dates Found